Synthetic retinoids for use in RAR mediated conditions

Iain Robert Greig; Peter John Andrew McCaffery; Andrew Whiting; Roy Valentine; David Chisholm; Thabat Khatib

Synthetic retinoids for use in RAR mediated conditions

Iain Robert Greig (Inventor), Peter John Andrew McCaffery (Inventor), Andrew Whiting (Inventor), Roy Valentine (Inventor), David Chisholm (Inventor), Thabat Khatib (Inventor)

Research output: Patent

Abstract

(EN)There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.

Original language	English
Patent number	WO2017174999
Publication status	Published - 12 Oct 2017

Access to Document

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017174999Licence: Unspecified

Cite this

@misc{10b55dade6a74d199deebb38e544ed3a,

title = "Synthetic retinoids for use in RAR mediated conditions",

abstract = "(EN)There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.",

author = "Greig, {Iain Robert} and McCaffery, {Peter John Andrew} and Andrew Whiting and Roy Valentine and David Chisholm and Thabat Khatib",

year = "2017",

month = oct,

day = "12",

language = "English",

type = "Patent",

note = "WO2017174999",

}

TY - PAT

T1 - Synthetic retinoids for use in RAR mediated conditions

AU - Greig, Iain Robert

AU - McCaffery, Peter John Andrew

AU - Whiting, Andrew

AU - Valentine, Roy

AU - Chisholm, David

AU - Khatib, Thabat

PY - 2017/10/12

Y1 - 2017/10/12

N2 - (EN)There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.

AB - (EN)There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.

M3 - Patent

M1 - WO2017174999

ER -

Synthetic retinoids for use in RAR mediated conditions

Abstract

Access to Document

Fingerprint

Cite this